Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies

Suman Malempati, Douglas S. Hawkins

Research output: Contribution to journalArticle

170 Citations (Scopus)

Abstract

The prognosis for children and adolescents with rhabdomyosarcoma (RMS) has improved with refinements in multi-modal therapy. Since 1972, the Intergroup Rhabdomyosarcoma Study Group (now the Children's Oncology Group Soft-Tissue Sarcoma Committee) has conducted serial studies for RMS. This review describes the IRSG and COG experience with RMS, presents the current risk stratification definitions, and provides rationale for the current generation of COG RMS studies.

Original languageEnglish (US)
Pages (from-to)5-10
Number of pages6
JournalPediatric Blood and Cancer
Volume59
Issue number1
DOIs
StatePublished - Jul 15 2012

Fingerprint

Rhabdomyosarcoma
Sarcoma

Keywords

  • Pediatric
  • Rhabdomyosarcoma
  • Soft-tissue sarcoma

ASJC Scopus subject areas

  • Oncology
  • Pediatrics, Perinatology, and Child Health
  • Hematology

Cite this

@article{685ade51ef0142b488d17e3dacf9e4fc,
title = "Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies",
abstract = "The prognosis for children and adolescents with rhabdomyosarcoma (RMS) has improved with refinements in multi-modal therapy. Since 1972, the Intergroup Rhabdomyosarcoma Study Group (now the Children's Oncology Group Soft-Tissue Sarcoma Committee) has conducted serial studies for RMS. This review describes the IRSG and COG experience with RMS, presents the current risk stratification definitions, and provides rationale for the current generation of COG RMS studies.",
keywords = "Pediatric, Rhabdomyosarcoma, Soft-tissue sarcoma",
author = "Suman Malempati and Hawkins, {Douglas S.}",
year = "2012",
month = "7",
day = "15",
doi = "10.1002/pbc.24118",
language = "English (US)",
volume = "59",
pages = "5--10",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Rhabdomyosarcoma

T2 - Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies

AU - Malempati, Suman

AU - Hawkins, Douglas S.

PY - 2012/7/15

Y1 - 2012/7/15

N2 - The prognosis for children and adolescents with rhabdomyosarcoma (RMS) has improved with refinements in multi-modal therapy. Since 1972, the Intergroup Rhabdomyosarcoma Study Group (now the Children's Oncology Group Soft-Tissue Sarcoma Committee) has conducted serial studies for RMS. This review describes the IRSG and COG experience with RMS, presents the current risk stratification definitions, and provides rationale for the current generation of COG RMS studies.

AB - The prognosis for children and adolescents with rhabdomyosarcoma (RMS) has improved with refinements in multi-modal therapy. Since 1972, the Intergroup Rhabdomyosarcoma Study Group (now the Children's Oncology Group Soft-Tissue Sarcoma Committee) has conducted serial studies for RMS. This review describes the IRSG and COG experience with RMS, presents the current risk stratification definitions, and provides rationale for the current generation of COG RMS studies.

KW - Pediatric

KW - Rhabdomyosarcoma

KW - Soft-tissue sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84861214958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861214958&partnerID=8YFLogxK

U2 - 10.1002/pbc.24118

DO - 10.1002/pbc.24118

M3 - Article

C2 - 22378628

AN - SCOPUS:84861214958

VL - 59

SP - 5

EP - 10

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 1

ER -